Brain fog in Covid-19 patients can persist for months, study finds

  • 📰 CNN
  • ⏱ Reading Time:
  • 45 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 21%
  • Publisher: 95%

United States Headlines News

United States Latest News,United States Headlines

Cognitive impairment -- described as brain fog -- can persist for months in Covid-19 patients, even for some who were not hospitalized, according to a new study.

The research, published Friday in the journal JAMA Network Open, found that nearly a quarter of Covid-19 patients in a Mount Sinai Health System registry experienced some issues with their memory -- and although hospitalized patients were more likely to have such brain fog after a coronavirus infection, some outpatients had cognitive impairment too.

Here's how you can combat COVID-19 'brain fog' 10:57Among all the patients, the researchers found that 15% showed deficits in phonemic fluency in their speaking; 16% in a set of mental skills called their executive functioning; 18% showed deficits in their cognitive processing speed; 20% in their ability to process categories or lists; 23% in memory recall and 24% in memory encoding, among other impairments.

The authors noted the possibility for bias in the sample because patients came to Mount Sinai Health System because they were experiencing symptoms."The association of COVID-19 with executive functioning raises key questions regarding patients' long-term treatment," the researchers wrote."Future studies are needed to identify the risk factors and mechanisms underlying cognitive dysfunction as well as options for rehabilitation.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

CNN the unreliable sources of news of all time

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 4. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Pfizer, BioNTech report high efficacy of COVID-19 booster shot in studyPfizer Inc and German partner BioNTech SE on Thursday said data from a Phase III trial demonstrated high efficacy of a booster dose of their COVID-19 vaccine against the virus, including the Delta variant. I'm afraid, too high efficacy makes the virus turn into mutant form and danger for people who uses average or lower efficacy. Or people who don't get vaccinated It's the same 👾!
Source: Reuters - 🏆 2. / 97 Read more »

Study Finds Children To Be Vectors Of Covid-19 And Emerging VariantsA new study by researchers from Massachusetts General Hospital, Brigham and Women’s Hospital, MIT and Harvard Medical School has found that infants, children and adolescents are equally capable of carrying high levels of live, replicating SARS-CoV-2 in their respiratory secretions. Duh! No kidding I mean.... Have you ever seen a child?
Source: Forbes - 🏆 394. / 53 Read more »

German COVID-19 cases jump as state leaders seek federal backingA key measure of coronavirus infections in Germany rose sharply over the past week, figures showed on Friday, raising the prospect of tougher restrictions as winter approaches.
Source: Reuters - 🏆 2. / 97 Read more »

Pfizer says COVID-19 vaccine more than 90% effective in kidsKid-size doses of Pfizer’s COVID-19 vaccine appear safe and nearly 91% effective at preventing symptomatic infections in 5- to 11-year-olds, according to study details released Friday as the U.S. considers opening vaccinations to that age group. The shots could begin in early November — with the first children in line fully protected by Christmas — if regulators give the go-ahead. Details of Pfizer's study were posted online.
Source: YahooNews - 🏆 380. / 59 Read more »

Pfizer says COVID-19 vaccine more than 90% effective in kidsPfizer says kid-size doses of its COVID-19 vaccine are safe and nearly 91% effective at preventing symptomatic infections in elementary school children LOL. Only .1-2.0% of children who have caught covid have had to been hospitalized
Source: ABC - 🏆 471. / 51 Read more »

Pfizer says COVID-19 vaccine more than 90% effective in kidsKid-size doses of Pfizer’s COVID-19 vaccine appear safe and nearly 91% effective at preventing symptomatic infections in 5- to 11-year-olds, according to study details released Friday as the U.S. considers opening vaccinations to that age group. 'I say that I agree 100% with my own tweets' Oh. Only 91%. Wow. That’s…….wow Mac Donald says its burgers are good for your health !
Source: AP - 🏆 728. / 51 Read more »